Found 43 clinical trials
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
These signals might generate new insights and foster progress of targeted cancer treatment. The associated biomarker profiling module aims to set up a decentral biobank for future research on molecular alterations or central re-testing.
- 0 views
- 16 Feb, 2024
- 1 location
Guardant360 Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
- 0 views
- 05 Aug, 2020
NCI COVID-19 in Cancer Patients NCCAPS Study
Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects the outcomes of patients undergoing cancer treatment and how having cancer affects COVID-19.
- 0 views
- 16 Feb, 2024
- 576 locations
A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis
At present, the recommendation of neoadjuvant chemotherapy varies among guidelines especially between eastern and western countries. According to the updated Japanese gastric cancer treatment guidelines (ver.5), neoadjuvant chemotherapy is the recommended standard procedure for patients with cT2-4 stages. However, the acknowledgement of preoperative therapy accompanied by the higher risk of …
- 0 views
- 05 Aug, 2020
COVID-19 and Cancer Patients
Routinely collected data will be used to assess the morbidity and mortality of cancer patients following a positive COVID-19 infection.
- 0 views
- 01 Feb, 2023
- 1 location
Cancer Therapy Effects on the Heart
Anthracycline chemotherapies (e.g. doxorubicin, daunorubicin) is commonly given to treat pediatric cancer, and carries a risk of cardiotoxicity. Over the long term, children who receive these therapies have an increased risk of heart failure and early cardiovascular death. However, current strategies for identifying patients who are at risk prior to …
- 0 views
- 16 Feb, 2024
- 1 location
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.
- 0 views
- 05 Aug, 2020
A Longitudinal Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
Based on the literature, the pancreatic cancer treatment predictor biomarker, which is used in the domestic clinical field, is actually applied to the pancreatic cancer patient cohort of the National Cancer Center.
- 0 views
- 16 Feb, 2024
- 1 location
Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy
Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies published on the subject suggest an increased risk of development of OSAHS for these patients.
- 0 views
- 16 Feb, 2024
- 1 location
Serial Tumour Biopsies and Blood Biomarkers in Melanoma
The overall aim of this study will be to collect tumour biopsies, biomarkers present in the blood, and other biological specimens which can be used to try to understand why resistance to anti-cancer treatment occurs, and to develop predictive biomarkers of this resistance in patients with locally advanced and metastatic …
- 0 views
- 16 Feb, 2024
- 1 location